Insulin like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor-Reference-Cited by-同舟云学术

Insulin like growth factor-1 works synergistically with dopamine to attenuate diabetic retinopathy by downregulating vascular endothelial growth factor

Published:2022-05 Issue: Volume:149 Page:112868
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Upreti Shikha,Sen Seema,Nag Tapas Chandra,Ghosh Madhumita P.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference76 articles.

1. Sympathetic neurotransmission modulates expression of inflammatory markers in the rat retina;Steinle;Exp. Eye Res.,2007

2. Novel detection and restorative levodopa treatment for preclinical diabetic retinopathy;Motz;Diabetes,2020

3. Alterations in the retinal dopaminergic neuronal system in rats with streptozotocin-induced diabetes;Nishimura;J. Neurochem.,1985

4. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and ins2 akita -diabetic mouse retinas;Gastinger;Invest. Ophthalmol. Vis. Sci.,2006

5. U. States, dopamine deficiency mediates early rod-driven inner retinal dysfunction in diabetic mice;Kim;Invest Ophthalmol. Vis. Sci.,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGF-1 inhibits inflammation and accelerates angiogenesis via Ras/PI3K/IKK/NF-κB signaling pathways to promote wound healing;European Journal of Pharmaceutical Sciences;2024-09

2. Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms;Antioxidants;2024-05-12

3. From Insight to Eyesight: Unveiling the Secrets of the Insulin-Like Growth Factor Axis in Retinal Health;aging and disease;2024

4. Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy;Cell Death Discovery;2023-11-17

5. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07